Literature DB >> 8090721

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.

K Park1, S J Kim, Y J Bang, J G Park, N K Kim, A B Roberts, M B Sporn.   

Abstract

We have found several genetic changes in the TGF-beta-type II receptor gene in human gastric cancer cell lines resistant to the growth inhibitory effect of TGF-beta. Southern blot analysis showed deletion of the type II receptor gene in two of eight cell lines and amplification in another two lines. The single cell line we studied that is sensitive to growth inhibition by TGF-beta showed no structural abnormalities of the type II receptor gene. Some of the gastric cancer cells resistant to the growth inhibitory effect of TGF-beta express either truncated or no detectable TGF-beta type II receptor mRNAs, whereas the one that retains responsiveness to the growth inhibitory effect of TGF-beta expresses a full-size type II receptor mRNA. Immunoprecipitation followed by Western blot analysis showed parallel changes in TGF-beta type II receptor expression. Our results suggest that one of the possible mechanisms of escape from autocrine or paracrine growth control by TGF-beta during carcinogenesis could involve genetic changes in the TGF-beta type II receptor gene itself or altered expression of its mRNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090721      PMCID: PMC44688          DOI: 10.1073/pnas.91.19.8772

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases.

Authors:  H Y Lin; H F Lodish
Journal:  Trends Cell Biol       Date:  1993-01       Impact factor: 20.808

2.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor.

Authors:  F T Boyd; J Massagué
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

3.  Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines.

Authors:  J H Kim; T Takahashi; I Chiba; J G Park; M J Birrer; J K Roh; H De Lee; J P Kim; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1991-07-03       Impact factor: 13.506

4.  Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.

Authors:  R Ebner; R H Chen; L Shum; S Lawler; T F Zioncheck; A Lee; A R Lopez; R Derynck
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

Review 5.  Transforming growth factor-beta.

Authors:  J Massagué; S Cheifetz; M Laiho; D A Ralph; F M Weis; A Zentella
Journal:  Cancer Surv       Date:  1992

6.  Characteristics of cell lines established from human gastric carcinoma.

Authors:  J G Park; H Frucht; R V LaRocca; D P Bliss; Y Kurita; T R Chen; J G Henslee; J B Trepel; R T Jensen; B E Johnson
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

7.  Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene.

Authors:  T Sakai; N Ohtani; T L McGee; P D Robbins; T P Dryja
Journal:  Nature       Date:  1991-09-05       Impact factor: 49.962

8.  Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.

Authors:  M Ito; W Yasui; E Kyo; H Yokozaki; H Nakayama; H Ito; E Tahara
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

9.  Molecular mechanism of stomach carcinogenesis.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas.

Authors:  M Ito; W Yasui; H Nakayama; H Yokozaki; H Ito; E Tahara
Journal:  Jpn J Cancer Res       Date:  1992-01
View more
  77 in total

1.  DNA methylation and carcinogenesis in digestive neoplasms.

Authors:  Javed Yakoob; Xue-Gong Fan; Guo-Ling Hu; Zheng Zhang
Journal:  World J Gastroenterol       Date:  1998-04       Impact factor: 5.742

2.  Relationship between grade of microsatellite instability and target genes of mismatch repair pathways in sporadic colorectal carcinoma.

Authors:  G Togo; Y Shiratori; M Okamoto; Y Yamaji; M Matsumura; T Sano; T Motojima; M Omata
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

Review 3.  The microRNA-17-92 family of microRNA clusters in development and disease.

Authors:  Carla P Concepcion; Ciro Bonetti; Andrea Ventura
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

4.  Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.

Authors:  M A Lynch; T A Petrel; H Song; T J Knobloch; B C Casto; D Ramljak; L M Anderson; V DeGroff; G D Stoner; R W Brueggemeier; C M Weghorst
Journal:  Gene Expr       Date:  2001

5.  Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.

Authors:  L Jin; X Qian; E Kulig; N Sanno; B W Scheithauer; K Kovacs; W F Young; R V Lloyd
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

6.  Role of Radiation-induced TGF-beta Signaling in Cancer Therapy.

Authors:  Horatiu C Dancea; Mohammed M Shareef; Mansoor M Ahmed
Journal:  Mol Cell Pharmacol       Date:  2009

7.  Suppressed Gastric Mucosal TGF-beta1 Increases Susceptibility to H. pylori-Induced Gastric Inflammation and Ulceration: A Stupid Host Defense Response.

Authors:  Yunjeong Jo; Sang Uk Han; Yoon Jae Kim; Ju Hyeon Kim; Shin Tae Kim; Seong-Jin Kim; Ki-Baik Hahm
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

Review 8.  The role of microsatellite instability in gastric carcinoma.

Authors:  J D Hayden; I G Martin; L Cawkwell; P Quirke
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

9.  15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.

Authors:  Min Yan; Ronald M Rerko; Petra Platzer; Dawn Dawson; Joseph Willis; Min Tong; Earl Lawrence; James Lutterbaugh; Shilong Lu; James K V Willson; Guangbin Luo; Jack Hensold; Hsin-Hsiung Tai; Keith Wilson; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

10.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.